Trimarchi, H <br/><br/>
Cyclosporine-associated thrombotic microangiopathy during daclizumab induction: a suggested therapeutic approach.  [electronic resource] 

 -  Nephron  Apr 2001 
 - 361-4 p.  digital 
<br/><br/> Publication Type: Case Reports; Journal Article 
<br/><br/><label>ISSN: </label>1660-8151 
<br/><br/><label>Standard No.: </label>10.1159/000045943  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antibodies, Monoclonal--therapeutic use<br/>Antibodies, Monoclonal, Humanized<br/>Biomarkers--blood<br/>Blood Component Transfusion<br/>Cyclosporine--adverse effects<br/>Daclizumab<br/>Drug Therapy, Combination<br/>Female<br/>Fibrin Fibrinogen Degradation Products--analysis<br/>Hemolysis<br/>Humans<br/>Immunoglobulin G--therapeutic use<br/>Immunosuppressive Agents--adverse effects<br/>Kidney Failure, Chronic--etiology<br/>Kidney Transplantation--immunology<br/>Living Donors<br/>Male<br/>Microcirculation--pathology<br/>Middle Aged<br/>Plasmapheresis<br/>Polycystic Kidney Diseases--complications<br/>Tacrolimus--therapeutic use<br/>Thrombosis--chemically induced